홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Thiazolo[4,5-c]pyridine → (6R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(1-carboxycyclobutyl)oxyiminoacetyl]amino]-8-oxo-3-([1,3]thiazolo[4,5-c]pyridin-5-ium-5-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

HRID 615790
노트
인쇄 미리보기

반응식

HRID 615790 반응식
C([O:5][C:6]([C:8]1([O:12]/[N:13]=[C:14](/[C:45]2[N:46]=[C:47]([NH:50]C(C3C=CC=CC=3)(C3C=CC=CC=3)C3C=CC=CC=3)[S:48][CH:49]=2)\[C:15]([NH:17][CH:18]2[C:43](=[O:44])[N:20]3[C:21]([C:27]([O:29]C(C4C=CC=CC=4)C4C=CC=CC=4)=[O:28])=[C:22]([CH2:25]I)[CH2:23][S:24][C@H:19]23)=[O:16])[CH2:11][CH2:10][CH2:9]1)=[O:7])(C)(C)C.[S:70]1[C:78]2[CH:77]=[CH:76][N:75]=[CH:74][C:73]=2[N:72]=[CH:71]1>CS(C)=O.CCOCC>[NH2:50][C:47]1[S:48][CH:49]=[C:45](/[C:14](=[N:13]/[O:12][C:8]2([C:6]([OH:5])=[O:7])[CH2:11][CH2:10][CH2:9]2)/[C:15]([NH:17][CH:18]2[C:43](=[O:44])[N:20]3[C:21]([C:27]([O-:29])=[O:28])=[C:22]([CH2:25][N+:75]4[CH:76]=[CH:77][C:78]5[S:70][CH:71]=[N:72][C:73]=5[CH:74]=4)[CH2:23][S:24][C@H:19]23)=[O:16])[N:46]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 585837Thiazolo[4,5-c]pyridineHCID 172953015benzhydryl (6R)-3-(iodomethyl)-7-[[(2Z)-2-[1-[(2-methylpropan-2-yl)oxycarbonyl]cyclobutyl]oxyimino-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

생성물 1

HCID 141546256(6R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(1-carboxycyclobutyl)oxyiminoacetyl]amino]-8-oxo-3-([1,3]thiazolo[4,5-c]pyridin-5-ium-5-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate수율 31%

시약·촉매·용매 2

HCID 679Dimethyl Sulfoxide용매HCID 3283Diethyl Ether용매

실험 절차

To a solution of diphenylmethyl 7-[(Z)-2-(1-t-butoxycarbonylcyclobut-1-oxyimino)-2-(2-tritylaminothiazol-4-yl)-acetamido]-3-iodomethyl-3-cephem-4-carboxylate [VIIe'] (482 mg, 0.45 mmole) in 2 mL of DMSO was added thiazolo[4,5-c]pyridine (68 mg, 0.5 mmole) in one portion. The mixture was stirred for 45 minutes at room temperature. The reaction mixture was then diluted with ether (50 mL) and the precipitated oil was triturated in ether (4×50 mL). The precipitate was mixed with anisole (0.5 mL), trifluoroacetic acid (5 mL) and water (0.5 mL), and the mixture was stirred with ice cooling for 30 minutes and at room temperature for 1 hour, and then was concentrated under reduced pressure (<30° C.). The residue was triturated with isopropyl ether (100 mL), and the resulting precipitate was collected by filtration to afford 395 mg of crude title compound, as a yellow powder. The crude product (387 mg) was purified on an HP-20 column (100 mL). The eluate containing desired product, which was eluted with 50% methanol, was concentrated and lyophilized to give 80 mg (31%) of the title product (Ie) as a pale yellow amorphous powder. Mp >170° C. (dec.).

후처리

  1. customthe precipitated oil was triturated in ether (4×50 mL)
  2. additionThe precipitate was mixed with anisole (0.5 mL), trifluoroacetic acid (5 mL) and water (0.5 mL)
  3. stirringthe mixture was stirred with ice cooling for 30 minutes and at room temperature for 1 hour
  4. concentrationwas concentrated under reduced pressure (<30° C.)
  5. customThe residue was triturated with isopropyl ether (100 mL)
  6. filtrationthe resulting precipitate was collected by filtration
  7. customto afford 395 mg of crude title compound
  8. customThe crude product (387 mg) was purified on an HP-20 column (100 mL)
  9. additionThe eluate containing desired product, which
  10. washwas eluted with 50% methanol
  11. concentrationwas concentrated

출처 및 근거

ORD 기록
ord-ae358299d736460b9bf4830f9cced679
출처 데이터셋
uspto-grants-1985_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04500526

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트